chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Carotid arteriosclerosis, Carotid artery stenosis, Chest X-ray abnormal, Computerised tomogram thorax abnormal
Clinical narrative: Patient is a 59 y.o. male with PMHx significant for ESRD, type 2 diabetes mellitus, hypertension, OSA who presented with altered mental status via EMS status post dialysis.  Patient desaturated initially and was escalated to BiPAP, reported to have required intubation. The patient was admitted to the Critical Care service for Ventilator management. Patient's mentation has dramatically improved and patient was extubated on 10/09 around noon without issue Consulted by ICU Team for Transfer of care.    Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary to volume overload, COVID Of note, pt was set up for home oxygen last admission (qualified for 2 L NC ATC) but refused DME delivery at home since he wanted a smaller tank Intubated on admission now extubated and requiring 2 L NC with ambulation Will try to set up Home oxygen again this admission   Covid-19 Virus Infection Date of onset of symptoms: 10/8/2022 Symptoms present on admission: hypoxia, weakness Date of covid positive test: 10/9/2022 Vaccination status: vaccinated Imaging: CT pulmonary arteries without PE and with Improved aeration of the lung bases with some residual atelectasis.   Oxygen requirements on admission: Intubated on admission Current oxygen requirements: 2 L NC with ambulation Medical therapy: dexamethasone until 10/19, covid cocktail Consultants following: none  Anticipated special isolation end date: 10/17/2022    Septic shock AF, wbc 3.7, UA without infection, CXR with overload MRSA probe +, Urine ag negative, Blood culture NGTD Required Levophed for a short time IV vancomycin and cefepime started on admission, now stopped PCT is stable at 0.7   ESRD on HD usually TTS Volume overload Hyperkalemia Nephrology following; RUE AVF HD x 3; labs and symptoms improved Pt declined HD today   Acute metabolic encephalopathy Likely secondary to CO2 narcosis from COVID and volume overload CTA showed no evidence of acute vessel occlusion no evidence of high-grade stenosis within the proximal large vessels.  Atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis; Moderate to marked occluders disease noted along the aortic arch with hypodense plaque noted along the periphery. Patient back to baseline Bilateral carotid stenosis CTA showed atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis OP monitoring   Thrombocytopenia Chronic, stable, asymptomatic   Elevated troponin Troponin 75-- >72 Likely combination of ESRD, septic shock Patient denies any chest pain
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Endotracheal intubation, Extubation, Hypercapnia, Hyperkalaemia, Hypervolaemia
Clinical narrative: Patient is a 59 y.o. male with PMHx significant for ESRD, type 2 diabetes mellitus, hypertension, OSA who presented with altered mental status via EMS status post dialysis.  Patient desaturated initially and was escalated to BiPAP, reported to have required intubation. The patient was admitted to the Critical Care service for Ventilator management. Patient's mentation has dramatically improved and patient was extubated on 10/09 around noon without issue Consulted by ICU Team for Transfer of care.    Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary to volume overload, COVID Of note, pt was set up for home oxygen last admission (qualified for 2 L NC ATC) but refused DME delivery at home since he wanted a smaller tank Intubated on admission now extubated and requiring 2 L NC with ambulation Will try to set up Home oxygen again this admission   Covid-19 Virus Infection Date of onset of symptoms: 10/8/2022 Symptoms present on admission: hypoxia, weakness Date of covid positive test: 10/9/2022 Vaccination status: vaccinated Imaging: CT pulmonary arteries without PE and with Improved aeration of the lung bases with some residual atelectasis.   Oxygen requirements on admission: Intubated on admission Current oxygen requirements: 2 L NC with ambulation Medical therapy: dexamethasone until 10/19, covid cocktail Consultants following: none  Anticipated special isolation end date: 10/17/2022    Septic shock AF, wbc 3.7, UA without infection, CXR with overload MRSA probe +, Urine ag negative, Blood culture NGTD Required Levophed for a short time IV vancomycin and cefepime started on admission, now stopped PCT is stable at 0.7   ESRD on HD usually TTS Volume overload Hyperkalemia Nephrology following; RUE AVF HD x 3; labs and symptoms improved Pt declined HD today   Acute metabolic encephalopathy Likely secondary to CO2 narcosis from COVID and volume overload CTA showed no evidence of acute vessel occlusion no evidence of high-grade stenosis within the proximal large vessels.  Atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis; Moderate to marked occluders disease noted along the aortic arch with hypodense plaque noted along the periphery. Patient back to baseline Bilateral carotid stenosis CTA showed atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis OP monitoring   Thrombocytopenia Chronic, stable, asymptomatic   Elevated troponin Troponin 75-- >72 Likely combination of ESRD, septic shock Patient denies any chest pain
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Malaise, Mechanical ventilation, Mental status changes, Metabolic encephalopathy
Clinical narrative: Patient is a 59 y.o. male with PMHx significant for ESRD, type 2 diabetes mellitus, hypertension, OSA who presented with altered mental status via EMS status post dialysis.  Patient desaturated initially and was escalated to BiPAP, reported to have required intubation. The patient was admitted to the Critical Care service for Ventilator management. Patient's mentation has dramatically improved and patient was extubated on 10/09 around noon without issue Consulted by ICU Team for Transfer of care.    Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary to volume overload, COVID Of note, pt was set up for home oxygen last admission (qualified for 2 L NC ATC) but refused DME delivery at home since he wanted a smaller tank Intubated on admission now extubated and requiring 2 L NC with ambulation Will try to set up Home oxygen again this admission   Covid-19 Virus Infection Date of onset of symptoms: 10/8/2022 Symptoms present on admission: hypoxia, weakness Date of covid positive test: 10/9/2022 Vaccination status: vaccinated Imaging: CT pulmonary arteries without PE and with Improved aeration of the lung bases with some residual atelectasis.   Oxygen requirements on admission: Intubated on admission Current oxygen requirements: 2 L NC with ambulation Medical therapy: dexamethasone until 10/19, covid cocktail Consultants following: none  Anticipated special isolation end date: 10/17/2022    Septic shock AF, wbc 3.7, UA without infection, CXR with overload MRSA probe +, Urine ag negative, Blood culture NGTD Required Levophed for a short time IV vancomycin and cefepime started on admission, now stopped PCT is stable at 0.7   ESRD on HD usually TTS Volume overload Hyperkalemia Nephrology following; RUE AVF HD x 3; labs and symptoms improved Pt declined HD today   Acute metabolic encephalopathy Likely secondary to CO2 narcosis from COVID and volume overload CTA showed no evidence of acute vessel occlusion no evidence of high-grade stenosis within the proximal large vessels.  Atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis; Moderate to marked occluders disease noted along the aortic arch with hypodense plaque noted along the periphery. Patient back to baseline Bilateral carotid stenosis CTA showed atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis OP monitoring   Thrombocytopenia Chronic, stable, asymptomatic   Elevated troponin Troponin 75-- >72 Likely combination of ESRD, septic shock Patient denies any chest pain
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Positive airway pressure therapy, Respiratory failure, SARS-CoV-2 test positive, Septic shock
Clinical narrative: Patient is a 59 y.o. male with PMHx significant for ESRD, type 2 diabetes mellitus, hypertension, OSA who presented with altered mental status via EMS status post dialysis.  Patient desaturated initially and was escalated to BiPAP, reported to have required intubation. The patient was admitted to the Critical Care service for Ventilator management. Patient's mentation has dramatically improved and patient was extubated on 10/09 around noon without issue Consulted by ICU Team for Transfer of care.    Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary to volume overload, COVID Of note, pt was set up for home oxygen last admission (qualified for 2 L NC ATC) but refused DME delivery at home since he wanted a smaller tank Intubated on admission now extubated and requiring 2 L NC with ambulation Will try to set up Home oxygen again this admission   Covid-19 Virus Infection Date of onset of symptoms: 10/8/2022 Symptoms present on admission: hypoxia, weakness Date of covid positive test: 10/9/2022 Vaccination status: vaccinated Imaging: CT pulmonary arteries without PE and with Improved aeration of the lung bases with some residual atelectasis.   Oxygen requirements on admission: Intubated on admission Current oxygen requirements: 2 L NC with ambulation Medical therapy: dexamethasone until 10/19, covid cocktail Consultants following: none  Anticipated special isolation end date: 10/17/2022    Septic shock AF, wbc 3.7, UA without infection, CXR with overload MRSA probe +, Urine ag negative, Blood culture NGTD Required Levophed for a short time IV vancomycin and cefepime started on admission, now stopped PCT is stable at 0.7   ESRD on HD usually TTS Volume overload Hyperkalemia Nephrology following; RUE AVF HD x 3; labs and symptoms improved Pt declined HD today   Acute metabolic encephalopathy Likely secondary to CO2 narcosis from COVID and volume overload CTA showed no evidence of acute vessel occlusion no evidence of high-grade stenosis within the proximal large vessels.  Atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis; Moderate to marked occluders disease noted along the aortic arch with hypodense plaque noted along the periphery. Patient back to baseline Bilateral carotid stenosis CTA showed atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis OP monitoring   Thrombocytopenia Chronic, stable, asymptomatic   Elevated troponin Troponin 75-- >72 Likely combination of ESRD, septic shock Patient denies any chest pain
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Staphylococcus test positive, Thrombocytopenia, Troponin increased, Urine analysis normal, Urine antigen test
Clinical narrative: Patient is a 59 y.o. male with PMHx significant for ESRD, type 2 diabetes mellitus, hypertension, OSA who presented with altered mental status via EMS status post dialysis.  Patient desaturated initially and was escalated to BiPAP, reported to have required intubation. The patient was admitted to the Critical Care service for Ventilator management. Patient's mentation has dramatically improved and patient was extubated on 10/09 around noon without issue Consulted by ICU Team for Transfer of care.    Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary to volume overload, COVID Of note, pt was set up for home oxygen last admission (qualified for 2 L NC ATC) but refused DME delivery at home since he wanted a smaller tank Intubated on admission now extubated and requiring 2 L NC with ambulation Will try to set up Home oxygen again this admission   Covid-19 Virus Infection Date of onset of symptoms: 10/8/2022 Symptoms present on admission: hypoxia, weakness Date of covid positive test: 10/9/2022 Vaccination status: vaccinated Imaging: CT pulmonary arteries without PE and with Improved aeration of the lung bases with some residual atelectasis.   Oxygen requirements on admission: Intubated on admission Current oxygen requirements: 2 L NC with ambulation Medical therapy: dexamethasone until 10/19, covid cocktail Consultants following: none  Anticipated special isolation end date: 10/17/2022    Septic shock AF, wbc 3.7, UA without infection, CXR with overload MRSA probe +, Urine ag negative, Blood culture NGTD Required Levophed for a short time IV vancomycin and cefepime started on admission, now stopped PCT is stable at 0.7   ESRD on HD usually TTS Volume overload Hyperkalemia Nephrology following; RUE AVF HD x 3; labs and symptoms improved Pt declined HD today   Acute metabolic encephalopathy Likely secondary to CO2 narcosis from COVID and volume overload CTA showed no evidence of acute vessel occlusion no evidence of high-grade stenosis within the proximal large vessels.  Atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis; Moderate to marked occluders disease noted along the aortic arch with hypodense plaque noted along the periphery. Patient back to baseline Bilateral carotid stenosis CTA showed atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis OP monitoring   Thrombocytopenia Chronic, stable, asymptomatic   Elevated troponin Troponin 75-- >72 Likely combination of ESRD, septic shock Patient denies any chest pain
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count decreased
Clinical narrative: Patient is a 59 y.o. male with PMHx significant for ESRD, type 2 diabetes mellitus, hypertension, OSA who presented with altered mental status via EMS status post dialysis.  Patient desaturated initially and was escalated to BiPAP, reported to have required intubation. The patient was admitted to the Critical Care service for Ventilator management. Patient's mentation has dramatically improved and patient was extubated on 10/09 around noon without issue Consulted by ICU Team for Transfer of care.    Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary to volume overload, COVID Of note, pt was set up for home oxygen last admission (qualified for 2 L NC ATC) but refused DME delivery at home since he wanted a smaller tank Intubated on admission now extubated and requiring 2 L NC with ambulation Will try to set up Home oxygen again this admission   Covid-19 Virus Infection Date of onset of symptoms: 10/8/2022 Symptoms present on admission: hypoxia, weakness Date of covid positive test: 10/9/2022 Vaccination status: vaccinated Imaging: CT pulmonary arteries without PE and with Improved aeration of the lung bases with some residual atelectasis.   Oxygen requirements on admission: Intubated on admission Current oxygen requirements: 2 L NC with ambulation Medical therapy: dexamethasone until 10/19, covid cocktail Consultants following: none  Anticipated special isolation end date: 10/17/2022    Septic shock AF, wbc 3.7, UA without infection, CXR with overload MRSA probe +, Urine ag negative, Blood culture NGTD Required Levophed for a short time IV vancomycin and cefepime started on admission, now stopped PCT is stable at 0.7   ESRD on HD usually TTS Volume overload Hyperkalemia Nephrology following; RUE AVF HD x 3; labs and symptoms improved Pt declined HD today   Acute metabolic encephalopathy Likely secondary to CO2 narcosis from COVID and volume overload CTA showed no evidence of acute vessel occlusion no evidence of high-grade stenosis within the proximal large vessels.  Atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis; Moderate to marked occluders disease noted along the aortic arch with hypodense plaque noted along the periphery. Patient back to baseline Bilateral carotid stenosis CTA showed atherosclerotic plaque visualized in the bilateral carotid bifurcations with less than 50% stenosis OP monitoring   Thrombocytopenia Chronic, stable, asymptomatic   Elevated troponin Troponin 75-- >72 Likely combination of ESRD, septic shock Patient denies any chest pain
Age: 0.92
Sex: M
Vaccine: COVID19
Symptoms: Cough, Ear infection, Eye discharge, Nasopharyngitis, Pyrexia
Clinical narrative: He had a cough, runny nose, a little discharge from his eyes from an ear infection, low grade fever for a day or two. His symptoms lasted about seven days were very mild and then he was back to being himself. We took him in to see the doctor and he was given amoxicillin for the ear infection. He acted more like he had a mild cold.
Age: 0.92
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: He had a cough, runny nose, a little discharge from his eyes from an ear infection, low grade fever for a day or two. His symptoms lasted about seven days were very mild and then he was back to being himself. We took him in to see the doctor and he was given amoxicillin for the ear infection. He acted more like he had a mild cold.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Administered booster dose of Moderna (blue top).  Person should have received Moderna Bivalent booster (blue top).  No adverse event occurred.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Joint stiffness
Clinical narrative: Steroid injection into the tight knee
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Blood creatinine increased, Blood potassium decreased, Bronchitis viral, COVID-19
Clinical narrative: Patient is a 75 y.o. female patient of, MD with history of HTN, HL, CKD who presented with cough, nausea, vomiting, fevers, chills, found to have COVID 19.    Covid-19 Virus Infection Acute viral bronchitis  Date of onset of symptoms: 9/25/2022 Symptoms present on admission: nausea, vomiting, cough, fevers Date of covid positive test: 9/28/2022 Vaccination status: vaccinated Imaging: CXR on and on 10/1 admit negative  Oxygen requirements on admission: none  Current oxygen requirements: 95% on room air Medical therapy: decadron and doxycycline for bronchitis and wheezing  Consultants following: none  Anticipated special isolation end date: 10/5/2022 Supportive care Albuterol inhaler scheduled, mucinex, hycodan and tessalon prn for cough.  Acetaminophen and robaxin scheduled  Doxycycline and decadron added 10/1 for bronchitis and wheezing  Cough, wheezing significantly improved 10/2, saturating well on room air   Home O2 eval completed and no home needs identified   Chest pain Left side precordial pain, constant since early this morning. Not reproducible but worse intermittently with deep breaths.  Overall cough, resp status and oxygen levels improving, low suspicion for PE Suspect musculoskeletal etiology  CXR was negative on admit and on 10/1 I independently reviewed the EKG showing Twi in I, aVL, appear similar to previous, no acute ischemic ST-T changes Trops 28, flat no further cardiac testing warranted Recommend ibuprofen for chest pain relief   AKI on stage III CKD Cr 2.48 on admit, baseline is 1.5-2.0 Likely prerenal due to volume depletion Received 1 L bolus in ED, s/p continuous fluids, 500 cc bolus on 10/1  Cr improving,  1.93 9/28, stopped IVF  Stable around 1.7  stopped home ACEi and hydrochlorothiazide as BP stable and AKI on admit Encouraging oral intake, drinking Boost   Hypertension Home meds: coreg, norvasc Bps 100-130s systolic Resume norvasc, resume coreg at reduced doseHyperlipidemia Resume statin   Hypokalemia(Resolved) K was 3.0 on admit, replaced Resolved now
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Chest pain, Chills, Chronic kidney disease, Condition aggravated
Clinical narrative: Patient is a 75 y.o. female patient of, MD with history of HTN, HL, CKD who presented with cough, nausea, vomiting, fevers, chills, found to have COVID 19.    Covid-19 Virus Infection Acute viral bronchitis  Date of onset of symptoms: 9/25/2022 Symptoms present on admission: nausea, vomiting, cough, fevers Date of covid positive test: 9/28/2022 Vaccination status: vaccinated Imaging: CXR on and on 10/1 admit negative  Oxygen requirements on admission: none  Current oxygen requirements: 95% on room air Medical therapy: decadron and doxycycline for bronchitis and wheezing  Consultants following: none  Anticipated special isolation end date: 10/5/2022 Supportive care Albuterol inhaler scheduled, mucinex, hycodan and tessalon prn for cough.  Acetaminophen and robaxin scheduled  Doxycycline and decadron added 10/1 for bronchitis and wheezing  Cough, wheezing significantly improved 10/2, saturating well on room air   Home O2 eval completed and no home needs identified   Chest pain Left side precordial pain, constant since early this morning. Not reproducible but worse intermittently with deep breaths.  Overall cough, resp status and oxygen levels improving, low suspicion for PE Suspect musculoskeletal etiology  CXR was negative on admit and on 10/1 I independently reviewed the EKG showing Twi in I, aVL, appear similar to previous, no acute ischemic ST-T changes Trops 28, flat no further cardiac testing warranted Recommend ibuprofen for chest pain relief   AKI on stage III CKD Cr 2.48 on admit, baseline is 1.5-2.0 Likely prerenal due to volume depletion Received 1 L bolus in ED, s/p continuous fluids, 500 cc bolus on 10/1  Cr improving,  1.93 9/28, stopped IVF  Stable around 1.7  stopped home ACEi and hydrochlorothiazide as BP stable and AKI on admit Encouraging oral intake, drinking Boost   Hypertension Home meds: coreg, norvasc Bps 100-130s systolic Resume norvasc, resume coreg at reduced doseHyperlipidemia Resume statin   Hypokalemia(Resolved) K was 3.0 on admit, replaced Resolved now
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Electrocardiogram T wave inversion, Hypokalaemia, Hypovolaemia, Nausea
Clinical narrative: Patient is a 75 y.o. female patient of, MD with history of HTN, HL, CKD who presented with cough, nausea, vomiting, fevers, chills, found to have COVID 19.    Covid-19 Virus Infection Acute viral bronchitis  Date of onset of symptoms: 9/25/2022 Symptoms present on admission: nausea, vomiting, cough, fevers Date of covid positive test: 9/28/2022 Vaccination status: vaccinated Imaging: CXR on and on 10/1 admit negative  Oxygen requirements on admission: none  Current oxygen requirements: 95% on room air Medical therapy: decadron and doxycycline for bronchitis and wheezing  Consultants following: none  Anticipated special isolation end date: 10/5/2022 Supportive care Albuterol inhaler scheduled, mucinex, hycodan and tessalon prn for cough.  Acetaminophen and robaxin scheduled  Doxycycline and decadron added 10/1 for bronchitis and wheezing  Cough, wheezing significantly improved 10/2, saturating well on room air   Home O2 eval completed and no home needs identified   Chest pain Left side precordial pain, constant since early this morning. Not reproducible but worse intermittently with deep breaths.  Overall cough, resp status and oxygen levels improving, low suspicion for PE Suspect musculoskeletal etiology  CXR was negative on admit and on 10/1 I independently reviewed the EKG showing Twi in I, aVL, appear similar to previous, no acute ischemic ST-T changes Trops 28, flat no further cardiac testing warranted Recommend ibuprofen for chest pain relief   AKI on stage III CKD Cr 2.48 on admit, baseline is 1.5-2.0 Likely prerenal due to volume depletion Received 1 L bolus in ED, s/p continuous fluids, 500 cc bolus on 10/1  Cr improving,  1.93 9/28, stopped IVF  Stable around 1.7  stopped home ACEi and hydrochlorothiazide as BP stable and AKI on admit Encouraging oral intake, drinking Boost   Hypertension Home meds: coreg, norvasc Bps 100-130s systolic Resume norvasc, resume coreg at reduced doseHyperlipidemia Resume statin   Hypokalemia(Resolved) K was 3.0 on admit, replaced Resolved now
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Painful respiration, Pyrexia, SARS-CoV-2 test positive, Troponin increased, Vomiting
Clinical narrative: Patient is a 75 y.o. female patient of, MD with history of HTN, HL, CKD who presented with cough, nausea, vomiting, fevers, chills, found to have COVID 19.    Covid-19 Virus Infection Acute viral bronchitis  Date of onset of symptoms: 9/25/2022 Symptoms present on admission: nausea, vomiting, cough, fevers Date of covid positive test: 9/28/2022 Vaccination status: vaccinated Imaging: CXR on and on 10/1 admit negative  Oxygen requirements on admission: none  Current oxygen requirements: 95% on room air Medical therapy: decadron and doxycycline for bronchitis and wheezing  Consultants following: none  Anticipated special isolation end date: 10/5/2022 Supportive care Albuterol inhaler scheduled, mucinex, hycodan and tessalon prn for cough.  Acetaminophen and robaxin scheduled  Doxycycline and decadron added 10/1 for bronchitis and wheezing  Cough, wheezing significantly improved 10/2, saturating well on room air   Home O2 eval completed and no home needs identified   Chest pain Left side precordial pain, constant since early this morning. Not reproducible but worse intermittently with deep breaths.  Overall cough, resp status and oxygen levels improving, low suspicion for PE Suspect musculoskeletal etiology  CXR was negative on admit and on 10/1 I independently reviewed the EKG showing Twi in I, aVL, appear similar to previous, no acute ischemic ST-T changes Trops 28, flat no further cardiac testing warranted Recommend ibuprofen for chest pain relief   AKI on stage III CKD Cr 2.48 on admit, baseline is 1.5-2.0 Likely prerenal due to volume depletion Received 1 L bolus in ED, s/p continuous fluids, 500 cc bolus on 10/1  Cr improving,  1.93 9/28, stopped IVF  Stable around 1.7  stopped home ACEi and hydrochlorothiazide as BP stable and AKI on admit Encouraging oral intake, drinking Boost   Hypertension Home meds: coreg, norvasc Bps 100-130s systolic Resume norvasc, resume coreg at reduced doseHyperlipidemia Resume statin   Hypokalemia(Resolved) K was 3.0 on admit, replaced Resolved now
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Patient is a 75 y.o. female patient of, MD with history of HTN, HL, CKD who presented with cough, nausea, vomiting, fevers, chills, found to have COVID 19.    Covid-19 Virus Infection Acute viral bronchitis  Date of onset of symptoms: 9/25/2022 Symptoms present on admission: nausea, vomiting, cough, fevers Date of covid positive test: 9/28/2022 Vaccination status: vaccinated Imaging: CXR on and on 10/1 admit negative  Oxygen requirements on admission: none  Current oxygen requirements: 95% on room air Medical therapy: decadron and doxycycline for bronchitis and wheezing  Consultants following: none  Anticipated special isolation end date: 10/5/2022 Supportive care Albuterol inhaler scheduled, mucinex, hycodan and tessalon prn for cough.  Acetaminophen and robaxin scheduled  Doxycycline and decadron added 10/1 for bronchitis and wheezing  Cough, wheezing significantly improved 10/2, saturating well on room air   Home O2 eval completed and no home needs identified   Chest pain Left side precordial pain, constant since early this morning. Not reproducible but worse intermittently with deep breaths.  Overall cough, resp status and oxygen levels improving, low suspicion for PE Suspect musculoskeletal etiology  CXR was negative on admit and on 10/1 I independently reviewed the EKG showing Twi in I, aVL, appear similar to previous, no acute ischemic ST-T changes Trops 28, flat no further cardiac testing warranted Recommend ibuprofen for chest pain relief   AKI on stage III CKD Cr 2.48 on admit, baseline is 1.5-2.0 Likely prerenal due to volume depletion Received 1 L bolus in ED, s/p continuous fluids, 500 cc bolus on 10/1  Cr improving,  1.93 9/28, stopped IVF  Stable around 1.7  stopped home ACEi and hydrochlorothiazide as BP stable and AKI on admit Encouraging oral intake, drinking Boost   Hypertension Home meds: coreg, norvasc Bps 100-130s systolic Resume norvasc, resume coreg at reduced doseHyperlipidemia Resume statin   Hypokalemia(Resolved) K was 3.0 on admit, replaced Resolved now
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Poor quality product administered
Clinical narrative: Vaccine given past expiry date of 09/30/2022 and past stability date of 10/19/2022.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Amyotrophic lateral sclerosis, Electromyogram, Limb immobilisation, Magnetic resonance imaging, Muscular weakness
Clinical narrative: Weakness in left index finger and thumb, followed by complete immobiliy of left hand, followed by no improvement for months, followed by EMG and cubital tunnel release on 8-16-2022 with no improvement in hand mobility, followed by patient of Neurosciences Clinic 10-5-22, followed by MRI and EMG at Univ. Utah on 10-28-22, followed by diagnosis of probable ALS, sent to Neurosciences ALS Clinic 11-30-2022.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral nerve decompression
Clinical narrative: Weakness in left index finger and thumb, followed by complete immobiliy of left hand, followed by no improvement for months, followed by EMG and cubital tunnel release on 8-16-2022 with no improvement in hand mobility, followed by patient of Neurosciences Clinic 10-5-22, followed by MRI and EMG at Univ. Utah on 10-28-22, followed by diagnosis of probable ALS, sent to Neurosciences ALS Clinic 11-30-2022.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: patient received the 5-11 year old monovalent vaccine, rather than bivalent booster
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt came in for the Pfizer Bivalent vaccine but was given the Pfizer Monovalent Vaccine.  The patient is doing well, no issues.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Administered booster dose of Moderna (blue top).  Person should have received Moderna Bivalent booster (blue top).  No adverse event occurred.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, Blood creatine phosphokinase normal, Blood culture negative, Blood fibrinogen increased
Clinical narrative: Patient is a 90 y.o. male patient of MD with history of TN, GERD  presented with generalized weakness with cough and shortness of breath.   Acute Respiratory Failure with hypoxemia-resolved COVID-19 nfection Sepsis without organ dysfunction  Vaccinated Presented with tachypnea and leukocytosis   Hemodynamically stable, not requiring vasopressors.  Lactic acid 1.9 on presentation COVID-19 symptoms: 10/4/22 COVID-19 test positive date: 10/5/22 CXR with no acute cardiopulmonary process Continue 2 liters/min via Nasal Canula; currently on room air Spo2>95% Fluid status euvolemic Blood cultures NGTD  UA no evidence of infection  D-dimer 0.63 , fibrinogen 484 CK 81 LDH 182  COVID-19 precautions for 10 days Albuterol via HFA q6PRN Tylenol prn for fever Continue IV Decadron; switch to oral Decadron remaining days total 10      Hypokalemia - resolved  K of 3.3 and Mag 1.9 on presentation Replace and recheck  Repeat K of 3.7 (10/07)   HTN  SBP 140s  Continue home medication regime    Pre -diabetes  HgbA1c 6.4 month ago 6.5 on admission      GERD  Continue home PPI
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactate dehydrogenase normal, Blood lactic acid, Blood magnesium, Blood potassium decreased, COVID-19
Clinical narrative: Patient is a 90 y.o. male patient of MD with history of TN, GERD  presented with generalized weakness with cough and shortness of breath.   Acute Respiratory Failure with hypoxemia-resolved COVID-19 nfection Sepsis without organ dysfunction  Vaccinated Presented with tachypnea and leukocytosis   Hemodynamically stable, not requiring vasopressors.  Lactic acid 1.9 on presentation COVID-19 symptoms: 10/4/22 COVID-19 test positive date: 10/5/22 CXR with no acute cardiopulmonary process Continue 2 liters/min via Nasal Canula; currently on room air Spo2>95% Fluid status euvolemic Blood cultures NGTD  UA no evidence of infection  D-dimer 0.63 , fibrinogen 484 CK 81 LDH 182  COVID-19 precautions for 10 days Albuterol via HFA q6PRN Tylenol prn for fever Continue IV Decadron; switch to oral Decadron remaining days total 10      Hypokalemia - resolved  K of 3.3 and Mag 1.9 on presentation Replace and recheck  Repeat K of 3.7 (10/07)   HTN  SBP 140s  Continue home medication regime    Pre -diabetes  HgbA1c 6.4 month ago 6.5 on admission      GERD  Continue home PPI
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray normal, Cough, Dyspnoea, Fibrin D dimer, Glucose tolerance impaired
Clinical narrative: Patient is a 90 y.o. male patient of MD with history of TN, GERD  presented with generalized weakness with cough and shortness of breath.   Acute Respiratory Failure with hypoxemia-resolved COVID-19 nfection Sepsis without organ dysfunction  Vaccinated Presented with tachypnea and leukocytosis   Hemodynamically stable, not requiring vasopressors.  Lactic acid 1.9 on presentation COVID-19 symptoms: 10/4/22 COVID-19 test positive date: 10/5/22 CXR with no acute cardiopulmonary process Continue 2 liters/min via Nasal Canula; currently on room air Spo2>95% Fluid status euvolemic Blood cultures NGTD  UA no evidence of infection  D-dimer 0.63 , fibrinogen 484 CK 81 LDH 182  COVID-19 precautions for 10 days Albuterol via HFA q6PRN Tylenol prn for fever Continue IV Decadron; switch to oral Decadron remaining days total 10      Hypokalemia - resolved  K of 3.3 and Mag 1.9 on presentation Replace and recheck  Repeat K of 3.7 (10/07)   HTN  SBP 140s  Continue home medication regime    Pre -diabetes  HgbA1c 6.4 month ago 6.5 on admission      GERD  Continue home PPI
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin increased, Hypertension, Hypokalaemia, Leukocytosis, Malaise
Clinical narrative: Patient is a 90 y.o. male patient of MD with history of TN, GERD  presented with generalized weakness with cough and shortness of breath.   Acute Respiratory Failure with hypoxemia-resolved COVID-19 nfection Sepsis without organ dysfunction  Vaccinated Presented with tachypnea and leukocytosis   Hemodynamically stable, not requiring vasopressors.  Lactic acid 1.9 on presentation COVID-19 symptoms: 10/4/22 COVID-19 test positive date: 10/5/22 CXR with no acute cardiopulmonary process Continue 2 liters/min via Nasal Canula; currently on room air Spo2>95% Fluid status euvolemic Blood cultures NGTD  UA no evidence of infection  D-dimer 0.63 , fibrinogen 484 CK 81 LDH 182  COVID-19 precautions for 10 days Albuterol via HFA q6PRN Tylenol prn for fever Continue IV Decadron; switch to oral Decadron remaining days total 10      Hypokalemia - resolved  K of 3.3 and Mag 1.9 on presentation Replace and recheck  Repeat K of 3.7 (10/07)   HTN  SBP 140s  Continue home medication regime    Pre -diabetes  HgbA1c 6.4 month ago 6.5 on admission      GERD  Continue home PPI
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Tachypnoea, Urine analysis normal
Clinical narrative: Patient is a 90 y.o. male patient of MD with history of TN, GERD  presented with generalized weakness with cough and shortness of breath.   Acute Respiratory Failure with hypoxemia-resolved COVID-19 nfection Sepsis without organ dysfunction  Vaccinated Presented with tachypnea and leukocytosis   Hemodynamically stable, not requiring vasopressors.  Lactic acid 1.9 on presentation COVID-19 symptoms: 10/4/22 COVID-19 test positive date: 10/5/22 CXR with no acute cardiopulmonary process Continue 2 liters/min via Nasal Canula; currently on room air Spo2>95% Fluid status euvolemic Blood cultures NGTD  UA no evidence of infection  D-dimer 0.63 , fibrinogen 484 CK 81 LDH 182  COVID-19 precautions for 10 days Albuterol via HFA q6PRN Tylenol prn for fever Continue IV Decadron; switch to oral Decadron remaining days total 10      Hypokalemia - resolved  K of 3.3 and Mag 1.9 on presentation Replace and recheck  Repeat K of 3.7 (10/07)   HTN  SBP 140s  Continue home medication regime    Pre -diabetes  HgbA1c 6.4 month ago 6.5 on admission      GERD  Continue home PPI
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Condition aggravated, Musculoskeletal stiffness, Pain
Clinical narrative: Exacerbation of joint pain; stiffness and body aches. I was already in PT for my joint pain and I was progressing until I received the vaccine. I have a follow up appointment on 11/18/2022.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: patient received the 5-11 year old monovalent vaccine, rather than bivalent booster
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: patient received the 5-11 year old monovalent vaccine, rather than bivalent booster
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Administered booster dose of Moderna (blue top).  Person should have received Moderna Bivalent booster (blue top).  No adverse event occurred.
Age: 74.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Chest pain, Cough, Hypersomnia, Lymphadenopathy, Musculoskeletal chest pain
Clinical narrative: I got my shot and she said, "oops, I missed the muscle." Then, my arm swelled up, my lymph nodes swelled up, I had nausea, vertigo, and vomited. I took TYLENOL, methocarbamol, meclizine, and went to sleep the rest of the day. I may or may not have taken and edible. I can't remember. I was coughing so hard that my chest and ribs started to hurt. Everything else has cleared up but the chest and rib pain.
Age: 74.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Nausea, Peripheral swelling, Product administration error, Vertigo, Vomiting
Clinical narrative: I got my shot and she said, "oops, I missed the muscle." Then, my arm swelled up, my lymph nodes swelled up, I had nausea, vertigo, and vomited. I took TYLENOL, methocarbamol, meclizine, and went to sleep the rest of the day. I may or may not have taken and edible. I can't remember. I was coughing so hard that my chest and ribs started to hurt. Everything else has cleared up but the chest and rib pain.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood creatinine increased, COVID-19 pneumonia, Cardiac failure, Cardiac failure congestive
Clinical narrative: The patient is a 89 y.o. male with history of CAD, CHF, CKD presented from the urgent care clinic for progressively worse SOA and lower extremity swelling.  His wife tested positive for COVID 4 days prior to admission.  Patient transferred for COVID pneumonia, CHF exacerbation, hypoxemia.   Acute hypoxemic respiratory failure secondary to COVID-pneumonia and CHF exacerbation Covid-19 Virus Infection Date of onset of symptoms: 9/30 Symptoms present on admission: Shortness of breath Date of covid positive test: 10/2 Vaccination status: vaccinated Imaging: CXR mild to moderate interstitial opacities throughout the lungs suggesting interstitial edema Oxygen requirements on admission: 2 L nasal cannula Needed HF, but now on RA at rest and needing 2L on ambulation for discharge Consultants following: Infectious disease Anticipated special isolation end date: 10/10 Started remdesivir and dexamethasone on 10/4 Discharge home on decadron     Acute HFrEF  HTN HLD CAD ECHO in 7/2021 with EF 35%, grade 2 diastolic dysfunction Patient with 1+ bilateral lower extremity edema but no crackles on exam, given insensible losses of respiratory failure 2/2 COVID-pneumonia  Started on IV diuresis with bumex Continue home Coreg, aspirin qOD, amlodipine, atorvastatin, Plavix, lisinopril  Bumex twice daily- discharge home on bumex 1 mg bid, and will resume lisinopril Fluid balance -7 L   CKD 3 Baseline GFR 25?29, stable on admission Cr at 1.79, around baseline Continue to monitor Resume lisinopril on discharge   Thrombocytopenia Platelets of 130  Likely due to infection improvd RLS Continue home Mirapex   BPH Continue home doxazosin   GERD Continue home famotidine
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Condition aggravated, Coronary artery disease, Diastolic dysfunction, Dyspnoea
Clinical narrative: The patient is a 89 y.o. male with history of CAD, CHF, CKD presented from the urgent care clinic for progressively worse SOA and lower extremity swelling.  His wife tested positive for COVID 4 days prior to admission.  Patient transferred for COVID pneumonia, CHF exacerbation, hypoxemia.   Acute hypoxemic respiratory failure secondary to COVID-pneumonia and CHF exacerbation Covid-19 Virus Infection Date of onset of symptoms: 9/30 Symptoms present on admission: Shortness of breath Date of covid positive test: 10/2 Vaccination status: vaccinated Imaging: CXR mild to moderate interstitial opacities throughout the lungs suggesting interstitial edema Oxygen requirements on admission: 2 L nasal cannula Needed HF, but now on RA at rest and needing 2L on ambulation for discharge Consultants following: Infectious disease Anticipated special isolation end date: 10/10 Started remdesivir and dexamethasone on 10/4 Discharge home on decadron     Acute HFrEF  HTN HLD CAD ECHO in 7/2021 with EF 35%, grade 2 diastolic dysfunction Patient with 1+ bilateral lower extremity edema but no crackles on exam, given insensible losses of respiratory failure 2/2 COVID-pneumonia  Started on IV diuresis with bumex Continue home Coreg, aspirin qOD, amlodipine, atorvastatin, Plavix, lisinopril  Bumex twice daily- discharge home on bumex 1 mg bid, and will resume lisinopril Fluid balance -7 L   CKD 3 Baseline GFR 25?29, stable on admission Cr at 1.79, around baseline Continue to monitor Resume lisinopril on discharge   Thrombocytopenia Platelets of 130  Likely due to infection improvd RLS Continue home Mirapex   BPH Continue home doxazosin   GERD Continue home famotidine
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Glomerular filtration rate decreased, Hyperlipidaemia, Hypertension, Hypoxia, Lung opacity
Clinical narrative: The patient is a 89 y.o. male with history of CAD, CHF, CKD presented from the urgent care clinic for progressively worse SOA and lower extremity swelling.  His wife tested positive for COVID 4 days prior to admission.  Patient transferred for COVID pneumonia, CHF exacerbation, hypoxemia.   Acute hypoxemic respiratory failure secondary to COVID-pneumonia and CHF exacerbation Covid-19 Virus Infection Date of onset of symptoms: 9/30 Symptoms present on admission: Shortness of breath Date of covid positive test: 10/2 Vaccination status: vaccinated Imaging: CXR mild to moderate interstitial opacities throughout the lungs suggesting interstitial edema Oxygen requirements on admission: 2 L nasal cannula Needed HF, but now on RA at rest and needing 2L on ambulation for discharge Consultants following: Infectious disease Anticipated special isolation end date: 10/10 Started remdesivir and dexamethasone on 10/4 Discharge home on decadron     Acute HFrEF  HTN HLD CAD ECHO in 7/2021 with EF 35%, grade 2 diastolic dysfunction Patient with 1+ bilateral lower extremity edema but no crackles on exam, given insensible losses of respiratory failure 2/2 COVID-pneumonia  Started on IV diuresis with bumex Continue home Coreg, aspirin qOD, amlodipine, atorvastatin, Plavix, lisinopril  Bumex twice daily- discharge home on bumex 1 mg bid, and will resume lisinopril Fluid balance -7 L   CKD 3 Baseline GFR 25?29, stable on admission Cr at 1.79, around baseline Continue to monitor Resume lisinopril on discharge   Thrombocytopenia Platelets of 130  Likely due to infection improvd RLS Continue home Mirapex   BPH Continue home doxazosin   GERD Continue home famotidine
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Oedema peripheral, Peripheral swelling, Platelet count decreased, Pulmonary oedema
Clinical narrative: The patient is a 89 y.o. male with history of CAD, CHF, CKD presented from the urgent care clinic for progressively worse SOA and lower extremity swelling.  His wife tested positive for COVID 4 days prior to admission.  Patient transferred for COVID pneumonia, CHF exacerbation, hypoxemia.   Acute hypoxemic respiratory failure secondary to COVID-pneumonia and CHF exacerbation Covid-19 Virus Infection Date of onset of symptoms: 9/30 Symptoms present on admission: Shortness of breath Date of covid positive test: 10/2 Vaccination status: vaccinated Imaging: CXR mild to moderate interstitial opacities throughout the lungs suggesting interstitial edema Oxygen requirements on admission: 2 L nasal cannula Needed HF, but now on RA at rest and needing 2L on ambulation for discharge Consultants following: Infectious disease Anticipated special isolation end date: 10/10 Started remdesivir and dexamethasone on 10/4 Discharge home on decadron     Acute HFrEF  HTN HLD CAD ECHO in 7/2021 with EF 35%, grade 2 diastolic dysfunction Patient with 1+ bilateral lower extremity edema but no crackles on exam, given insensible losses of respiratory failure 2/2 COVID-pneumonia  Started on IV diuresis with bumex Continue home Coreg, aspirin qOD, amlodipine, atorvastatin, Plavix, lisinopril  Bumex twice daily- discharge home on bumex 1 mg bid, and will resume lisinopril Fluid balance -7 L   CKD 3 Baseline GFR 25?29, stable on admission Cr at 1.79, around baseline Continue to monitor Resume lisinopril on discharge   Thrombocytopenia Platelets of 130  Likely due to infection improvd RLS Continue home Mirapex   BPH Continue home doxazosin   GERD Continue home famotidine
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Thrombocytopenia
Clinical narrative: The patient is a 89 y.o. male with history of CAD, CHF, CKD presented from the urgent care clinic for progressively worse SOA and lower extremity swelling.  His wife tested positive for COVID 4 days prior to admission.  Patient transferred for COVID pneumonia, CHF exacerbation, hypoxemia.   Acute hypoxemic respiratory failure secondary to COVID-pneumonia and CHF exacerbation Covid-19 Virus Infection Date of onset of symptoms: 9/30 Symptoms present on admission: Shortness of breath Date of covid positive test: 10/2 Vaccination status: vaccinated Imaging: CXR mild to moderate interstitial opacities throughout the lungs suggesting interstitial edema Oxygen requirements on admission: 2 L nasal cannula Needed HF, but now on RA at rest and needing 2L on ambulation for discharge Consultants following: Infectious disease Anticipated special isolation end date: 10/10 Started remdesivir and dexamethasone on 10/4 Discharge home on decadron     Acute HFrEF  HTN HLD CAD ECHO in 7/2021 with EF 35%, grade 2 diastolic dysfunction Patient with 1+ bilateral lower extremity edema but no crackles on exam, given insensible losses of respiratory failure 2/2 COVID-pneumonia  Started on IV diuresis with bumex Continue home Coreg, aspirin qOD, amlodipine, atorvastatin, Plavix, lisinopril  Bumex twice daily- discharge home on bumex 1 mg bid, and will resume lisinopril Fluid balance -7 L   CKD 3 Baseline GFR 25?29, stable on admission Cr at 1.79, around baseline Continue to monitor Resume lisinopril on discharge   Thrombocytopenia Platelets of 130  Likely due to infection improvd RLS Continue home Mirapex   BPH Continue home doxazosin   GERD Continue home famotidine
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoaesthesia, Injection site pain, Loss of personal independence in daily activities, Muscular weakness, Paraesthesia
Clinical narrative: Left arm numb, weak  and tingling interfering with sleep and  activities since Sunday (3 days now).   When given the shot  it hurt really bad and pharmacist said she must have hit a nerve.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sleep disorder
Clinical narrative: Left arm numb, weak  and tingling interfering with sleep and  activities since Sunday (3 days now).   When given the shot  it hurt really bad and pharmacist said she must have hit a nerve.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Respiratory tract irritation, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: On 11/05/2022 I had irritation in my lungs, runny nose and tiredness. I wrote email to my doctor on the same day. She replied to me back on 11/07/2022. She was going to prescribed me PAXLOVID because of the medication I take, she prescribed me LAGEVERIO (molnupiravir) 200 milligrams. I took 8 capsules per day instead.